IKBKE activity enhances AR levels in advanced prostate cancer via modulation of the Hippo pathway

Resistance to androgen receptor (AR) targeting therapeutics in prostate cancer (PC) is a significant clinical problem. Mechanisms by which this is accomplished include AR amplification and expression of AR splice variants, demonstrating that AR remains a key therapeutic target in advanced disease. F...

Descripción completa

Detalles Bibliográficos
Autores principales: Bainbridge, Alex, Walker, Scott, Smith, Joseph, Patterson, Kathryn, Dutt, Aparna, Ng, Yi Min, Thomas, Huw D, Wilson, Laura, McCullough, Benjamin, Jones, Dominic, Maan, Arussa, Banks, Peter, McCracken, Stuart R, Gaughan, Luke, Robson, Craig N, Coffey, Kelly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Gene regulation, Chromatin and Epigenetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261174/
https://www.ncbi.nlm.nih.gov/pubmed/32324216
http://dx.doi.org/10.1093/nar/gkaa271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261174/
https://www.ncbi.nlm.nih.gov/pubmed/32324216
http://dx.doi.org/10.1093/nar/gkaa271

Ejemplares similares